2021 Q3 Form 10-Q Financial Statement

#000143774921017780 Filed on July 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q3
Revenue $15.05M $12.63M $13.98M
YoY Change 7.63% 5.48% 80.39%
Cost Of Revenue $7.348M $6.206M $6.420M
YoY Change 14.45% 12.84% 53.96%
Gross Profit $7.699M $6.421M $7.560M
YoY Change 1.84% -0.77% 111.76%
Gross Profit Margin 51.17% 50.85% 54.08%
Selling, General & Admin $5.453M $4.776M $3.160M
YoY Change 72.56% 43.42% 10.88%
% of Gross Profit 70.83% 74.38% 41.8%
Research & Development $1.502M $1.125M $1.320M
YoY Change 13.79% -6.25% 32.0%
% of Gross Profit 19.51% 17.52% 17.46%
Depreciation & Amortization $644.0K $401.0K $180.0K
YoY Change 257.78% 95.61% -10.0%
% of Gross Profit 8.36% 6.25% 2.38%
Operating Expenses $6.955M $5.901M $4.490M
YoY Change 54.9% 30.26% 16.62%
Operating Profit $744.0K $520.0K $3.070M
YoY Change -75.77% -73.21% -1196.43%
Interest Expense $76.00K $228.0K $80.00K
YoY Change -5.0% -51.8%
% of Operating Profit 10.22% 43.85% 2.61%
Other Income/Expense, Net -$81.00K -$2.000K -$150.0K
YoY Change -46.0% -105.56% -266.67%
Pretax Income $699.0K $518.0K $3.000M
YoY Change -76.7% -73.8% -1766.67%
Income Tax -$72.00K $228.0K -$6.450M
% Of Pretax Income -10.3% 44.02% -215.0%
Net Earnings $771.0K $290.0K $9.450M
YoY Change -91.84% -80.72% -11912.5%
Net Earnings / Revenue 5.12% 2.3% 67.6%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $18.82K $0.01 $272.1K
COMMON SHARES
Basic Shares Outstanding 36.14M 34.11M
Diluted Shares Outstanding 35.27M

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.17M $20.52M $27.58M
YoY Change -52.26% -17.01% 22.52%
Cash & Equivalents $13.17M $14.54M $23.32M
Short-Term Investments $0.00 $5.976M $4.270M
Other Short-Term Assets $315.0K $231.0K $288.0K
YoY Change 9.38% 15.69% 0.0%
Inventory $6.416M $6.422M $5.949M
Prepaid Expenses
Receivables $7.682M $6.270M $5.442M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $35.49M $34.96M $40.12M
YoY Change -11.55% -12.07% 17.86%
LONG-TERM ASSETS
Property, Plant & Equipment $1.755M $1.836M $1.930M
YoY Change -9.07% -7.49% -14.94%
Goodwill $23.83M $23.91M $2.472M
YoY Change 864.16% 908.27% 7.2%
Intangibles $12.80M $13.43M $943.0K
YoY Change 1257.79% 1268.85% -19.81%
Long-Term Investments $1.875M $2.297M $3.810M
YoY Change -50.79% -31.23% 176.09%
Other Assets $9.513M $12.09M $11.62M
YoY Change -18.13% 134.28% 95.29%
Total Long-Term Assets $54.64M $58.61M $26.05M
YoY Change 109.76% 204.21% 99.13%
TOTAL ASSETS
Total Short-Term Assets $35.49M $34.96M $40.12M
Total Long-Term Assets $54.64M $58.61M $26.05M
Total Assets $90.13M $93.57M $66.17M
YoY Change 36.21% 58.52% 40.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.160M $2.708M $1.370M
YoY Change 57.66% -6.85% 59.3%
Accrued Expenses $14.11M $13.31M $7.880M
YoY Change 79.07% 49.78% -3.12%
Deferred Revenue $9.821M $10.19M $4.414M
YoY Change 122.5% 61.74% -20.78%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $296.0K $304.0K $300.0K
YoY Change -1.33% 5.73% 7.3%
Total Short-Term Liabilities $17.47M $17.19M $10.32M
YoY Change 69.23% 34.01% 11.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $18.00K
YoY Change -100.0% -100.0% -45.29%
Other Long-Term Liabilities $995.0K $5.420M $293.0K
YoY Change 239.59% 1313.62% -87.95%
Total Long-Term Liabilities $995.0K $5.420M $311.0K
YoY Change 219.94% 1253.88% -87.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.47M $17.19M $10.32M
Total Long-Term Liabilities $995.0K $5.420M $311.0K
Total Liabilities $24.17M $28.57M $17.03M
YoY Change 41.95% 44.15% 45.05%
SHAREHOLDERS EQUITY
Retained Earnings -$41.15M -$41.93M -$41.86M
YoY Change -1.68% -18.28% -22.1%
Common Stock $0.00 $0.00 $0.00
YoY Change -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $65.96M $65.00M $49.14M
YoY Change
Total Liabilities & Shareholders Equity $90.13M $93.57M $66.17M
YoY Change 36.21% 58.52% 40.42%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q3
OPERATING ACTIVITIES
Net Income $771.0K $290.0K $9.450M
YoY Change -91.84% -80.72% -11912.5%
Depreciation, Depletion And Amortization $644.0K $401.0K $180.0K
YoY Change 257.78% 95.61% -10.0%
Cash From Operating Activities -$2.164M $7.954M $3.210M
YoY Change -167.41% 36.2% -56.91%
INVESTING ACTIVITIES
Capital Expenditures -$27.00K -$31.00K -$30.00K
YoY Change -10.0% 210.0% -25.0%
Acquisitions
YoY Change
Other Investing Activities $710.0K -$11.83M -$690.0K
YoY Change -202.9% 420.97% 15.0%
Cash From Investing Activities $683.0K -$11.86M -$710.0K
YoY Change -196.2% 417.77% 10.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.00K 3.000K 140.0K
YoY Change -71.43% -99.59% -78.46%
NET CHANGE
Cash From Operating Activities -2.164M 7.954M 3.210M
Cash From Investing Activities 683.0K -11.86M -710.0K
Cash From Financing Activities 40.00K 3.000K 140.0K
Net Change In Cash -1.441M -3.900M 2.640M
YoY Change -154.58% -190.91% -64.61%
FREE CASH FLOW
Cash From Operating Activities -$2.164M $7.954M $3.210M
Capital Expenditures -$27.00K -$31.00K -$30.00K
Free Cash Flow -$2.137M $7.985M $3.240M
YoY Change -165.96% 36.5% -56.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36142093
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36142093
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36142093
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33561544
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33561544
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P7Y
us-gaap Dividends
Dividends
0 USD
CY2020 us-gaap Dividends
Dividends
0 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14540000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23319000 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5976000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4265000 USD
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
286000 USD
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
282000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6270000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5442000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
6422000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
5949000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1464000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
860000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
34958000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
40117000 USD
CY2021Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
2297000 USD
CY2020Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3805000 USD
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1202000 USD
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
395000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10694000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11095000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1836000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1930000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
23908000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
2472000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13431000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
943000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5048000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5285000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
193000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
125000 USD
CY2021Q2 us-gaap Assets
Assets
93567000 USD
CY2020Q3 us-gaap Assets
Assets
66167000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2708000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1370000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13305000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7880000 USD
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
304000 USD
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
300000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
877000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
771000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17194000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10321000 USD
CY2021Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2020Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
18000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5420000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
293000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5952000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6395000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
28566000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
17027000 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
106602000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91248000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41925000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41858000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
324000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-250000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
65001000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
49140000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93567000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66167000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12627000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11971000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31956000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
29029000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
5941000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
5500000 USD
us-gaap Cost Of Revenue
CostOfRevenue
16229000 USD
us-gaap Cost Of Revenue
CostOfRevenue
13946000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
6686000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
6471000 USD
us-gaap Gross Profit
GrossProfit
15727000 USD
us-gaap Gross Profit
GrossProfit
15083000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4776000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3330000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11931000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8884000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1390000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1200000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3416000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3233000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
6166000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
4530000 USD
us-gaap Operating Expenses
OperatingExpenses
15347000 USD
us-gaap Operating Expenses
OperatingExpenses
12117000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
520000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1941000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
380000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2966000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
202000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
518000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1977000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
473000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
506000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
742000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
290000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1504000 USD
us-gaap Net Income Loss
NetIncomeLoss
-67000 USD
us-gaap Net Income Loss
NetIncomeLoss
2426000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
439000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3168000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
228000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34109167
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33289426
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33797774
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33122042
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35270945
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34280915
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33797774
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33878243
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
290000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1504000 USD
us-gaap Net Income Loss
NetIncomeLoss
-67000 USD
us-gaap Net Income Loss
NetIncomeLoss
2426000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
182000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
43000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
579000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
70000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
473000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1555000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
507000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2493000 USD
us-gaap Net Income Loss
NetIncomeLoss
-67000 USD
us-gaap Net Income Loss
NetIncomeLoss
2426000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
953000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
620000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
gnss Product Warranty Expense Benefit
ProductWarrantyExpenseBenefit
44000 USD
gnss Product Warranty Expense Benefit
ProductWarrantyExpenseBenefit
2000 USD
us-gaap Inventory Write Down
InventoryWriteDown
315000 USD
us-gaap Inventory Write Down
InventoryWriteDown
168000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
956000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
776000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
48000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-0 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
28000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-0 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
506000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
742000 USD
gnss Operating Lease Rightofuse Asset Amortization Expense
OperatingLeaseRightofuseAssetAmortizationExpense
518000 USD
gnss Operating Lease Rightofuse Asset Amortization Expense
OperatingLeaseRightofuseAssetAmortizationExpense
446000 USD
us-gaap Accretion Expense
AccretionExpense
34000 USD
us-gaap Accretion Expense
AccretionExpense
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
574000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2722000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
788000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1667000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
636000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-732000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1134000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2040000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5988000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
148000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8314000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3711000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4457000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5497000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4249000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3183000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
15848000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
181000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
111000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16237000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2425000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
170000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
996000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
398000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
141000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
41000 USD
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
18000 USD
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
17000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
38000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
540000 USD
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-18000 USD
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-9000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7968000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1817000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23996000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19517000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16028000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21334000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14540000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20668000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
286000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
271000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1202000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
395000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16028000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21334000 USD
gnss Noncash Or Part Noncash Unrealized Loss On Marketable Securities
NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities
-6000 USD
gnss Noncash Or Part Noncash Unrealized Loss On Marketable Securities
NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities
-3000 USD
gnss Initial Measurement Of Operating Lease Right Of Use Assets
InitialMeasurementOfOperatingLeaseRightOfUseAssets
259000 USD
gnss Initial Measurement Of Operating Lease Right Of Use Assets
InitialMeasurementOfOperatingLeaseRightOfUseAssets
5824000 USD
gnss Initial Measurement Of Operating Lease Liabilities
InitialMeasurementOfOperatingLeaseLiabilities
259000 USD
gnss Initial Measurement Of Operating Lease Liabilities
InitialMeasurementOfOperatingLeaseLiabilities
7815000 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
30980000 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em> OPERATIONS </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Genasys Inc. (formerly LRAD® Corporation), a Delaware corporation (the “Company”), is engaged in the design, development and commercialization of directed and multidirectional sound technologies, voice broadcast products, location-based mass messaging solutions for emergency warning and enterprise safety, and evacuation planning and public safety resources. The principal markets for the Company’s proprietary sound reproduction technologies, voice broadcast products mass messaging solutions and public safety resources are in North and South America, Europe, the Middle East and Asia. On <em style="font: inherit;"> October 23, 2019, </em>the Company announced its rebranding and began doing business as Genasys Inc.</p>
CY2021Q2 gnss Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
8 pure
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14540000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23319000 USD
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
286000 USD
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1202000 USD
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
282000 USD
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
395000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4673000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4429000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2837000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2499000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Reclassifications </span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q2 us-gaap Share Price
SharePrice
5.05
CY2020Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
255000 USD
CY2020Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
106000 USD
CY2020Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
194000 USD
CY2020Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
2729000 USD
CY2020Q4 us-gaap Share Price
SharePrice
5.98
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4707000 USD
gnss Contract With Customer Liability Increase For New Contract
ContractWithCustomerLiabilityIncreaseForNewContract
14997000 USD
gnss Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
7535000 USD
gnss Contract With Customer Liability Effect Of Exchange Rate
ContractWithCustomerLiabilityEffectOfExchangeRate
-16000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12185000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1998000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10187000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12185000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10187000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.84 pure
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
5557000 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5220000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
797000 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
841000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
791000 USD
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
456000 USD
CY2021Q2 us-gaap Inventory Gross
InventoryGross
7145000 USD
CY2020Q3 us-gaap Inventory Gross
InventoryGross
6517000 USD
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
723000 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
568000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
6422000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
5949000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1836000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1930000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
106000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
131000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
2472000 USD
us-gaap Depreciation
Depreciation
306000 USD
us-gaap Depreciation
Depreciation
397000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
13128000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
20992000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
444000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
23908000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14979000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1829000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1548000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
886000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13431000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
943000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
295000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
74000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
647000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
223000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
546000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2185000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2152000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2138000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2007000 USD
CY2021Q2 gnss Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
4403000 USD
CY2021Q2 gnss Finite Lived Intangible Assets Amortization Expense Total
FiniteLivedIntangibleAssetsAmortizationExpenseTotal
13431000 USD
CY2021Q2 gnss Deposits For Inventory
DepositsForInventory
528000 USD
CY2020Q3 gnss Deposits For Inventory
DepositsForInventory
54000 USD
CY2021Q2 us-gaap Prepaid Insurance
PrepaidInsurance
355000 USD
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
264000 USD
CY2021Q2 gnss Due And Subscription
DueAndSubscription
255000 USD
CY2020Q3 gnss Due And Subscription
DueAndSubscription
151000 USD
CY2021Q2 gnss Prepaid Trade Shows And Travel
PrepaidTradeShowsAndTravel
95000 USD
CY2020Q3 gnss Prepaid Trade Shows And Travel
PrepaidTradeShowsAndTravel
103000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
231000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
288000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1464000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
860000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2705000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2545000 USD
CY2021Q2 gnss Accrued Contract Costs
AccruedContractCosts
89000 USD
CY2020Q3 gnss Accrued Contract Costs
AccruedContractCosts
719000 USD
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
143000 USD
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
126000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
181000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
76000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13305000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7880000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
259000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
518000 USD
gnss Effect Of Exchange Rate On Operating Lease Rou Assets
EffectOfExchangeRateOnOperatingLeaseROUAssets
22000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5048000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7166000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
259000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
618000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2729000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
693000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5420000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
293000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
126000 USD
CY2019Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
150000 USD
gnss Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties
ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties
44000 USD
CY2020 gnss Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties
ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties
16000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
27000 USD
CY2020 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
40000 USD
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
143000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
126000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
304000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
304000 USD
gnss Increase In Lease Liability With10 Increase In Index
IncreaseInLeaseLiabilityWith10IncreaseInIndex
19000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5285000 USD
gnss Effect Of Exchange Rate On Operating Lease Liability
EffectOfExchangeRateOnOperatingLeaseLiability
22000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
6829000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5952000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
877000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M9D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0412 pure
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
292000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1144000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1091000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1086000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1162000 USD
CY2021Q2 gnss Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
3104000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7879000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1050000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
6829000 USD
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
246000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
228000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
735000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
674000 USD
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 USD
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
506000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2248 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
742000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.228 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.97
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2743718
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
1505000 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
1143000 USD
CY2020Q4 us-gaap Share Price
SharePrice
5.98
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8251302
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
275000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1133727
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.485 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.445 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.006 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.014 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M24D
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
787000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2659305
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
275000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
104125
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.57
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
86462
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.00
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1520058
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.19
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y25D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7150000 USD
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5049000 USD
CY2021Q2 us-gaap Share Price
SharePrice
5.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
455000 USD
gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
170000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1236000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
996000 USD
CY2021Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2743718
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y25D
CY2021Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.00
CY2021Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1520058
CY2021Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.19
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
446000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
322000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
956000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
776000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
49140000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
182000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000 USD
CY2020Q4 gnss Adjustments To Additional Paid In Capital Stock Obligation To Issue Acquisition
AdjustmentsToAdditionalPaidInCapitalStockObligationToIssueAcquisition
3431000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
469000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-619000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
52657000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
328000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
116000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
141000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-78000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
262000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
53144000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
446000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
10938000 USD
CY2021Q2 gnss Stock Released From Obligation To Issue Value
StockReleasedFromObligationToIssueValue
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
183000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
290000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
65001000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
35381000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
158000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
144000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
85000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
620000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
36388000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
296000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
114000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
41000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
398000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-69000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
302000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
36592000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
322000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
738000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
51000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1504000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
39207000 USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
86462
gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
170000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
512019
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
996000 USD
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
206560
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
185043
CY2021Q2 us-gaap Share Price
SharePrice
5.05
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
290000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1504000 USD
us-gaap Net Income Loss
NetIncomeLoss
-67000 USD
us-gaap Net Income Loss
NetIncomeLoss
2426000 USD
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
893750
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
756201
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3560285
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
893750
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35270945
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34280915
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33797774
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33878243
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1487098
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2021Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
34109167
CY2020Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
33289426
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
33797774
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
33122042
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1161778
CY2020Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
991489
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12627000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11971000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31956000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
29029000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
520000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1941000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
380000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2966000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
401000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
205000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
953000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
620000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
228000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
473000 USD
us-gaap Interest Expense
InterestExpense
506000 USD
us-gaap Interest Expense
InterestExpense
742000 USD
CY2021Q2 us-gaap Noncurrent Assets
NoncurrentAssets
39175000 USD
CY2020Q3 us-gaap Noncurrent Assets
NoncurrentAssets
5345000 USD
CY2021Q2 us-gaap Assets
Assets
93567000 USD
CY2020Q3 us-gaap Assets
Assets
66167000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12627000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11971000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31956000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
29029000 USD

Files In Submission

Name View Source Status
0001437749-21-017780-index-headers.html Edgar Link pending
0001437749-21-017780-index.html Edgar Link pending
0001437749-21-017780.txt Edgar Link pending
0001437749-21-017780-xbrl.zip Edgar Link pending
ex_266498.htm Edgar Link pending
ex_266499.htm Edgar Link pending
ex_266500.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g01.jpg Edgar Link pending
gnss-20210630.xsd Edgar Link pending
gnss-20210630_cal.xml Edgar Link unprocessable
gnss-20210630_def.xml Edgar Link unprocessable
gnss-20210630_lab.xml Edgar Link unprocessable
gnss-20210630_pre.xml Edgar Link unprocessable
gnss20210630_10q.htm Edgar Link pending
gnss20210630_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending